Evidence map›Paper›PMID 35496273›Full record

ArticleFrontiers in pharmacology2022

Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis

Yuhui Chai, Yawen Cai, Yu Fu, Yingdi Wang, Yiming Zhang, Xue Zhang, Lingpeng Zhu, Mingxing Miao, Tianhua Yan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 87 citations in OpenAlex.

  1. Salidroside in heavy metal toxicity: a mechanistic review of antioxidant, anti-inflammatory, and anti-apoptotic pathways.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuhui ChaiDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
Yawen CaiDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
Yu FuDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
Yingdi WangDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
Yiming ZhangDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
Xue ZhangDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
Lingpeng ZhuCenter of Clinical Research, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Mingxing MiaoCenter of National Pharmaceutical Experimental Teaching Demonstration, China Pharmaceutic University, Nanjing, China.
Tianhua YanDepartment of Physiology and Pharmacology, China Pharmaceutic University, Nanjing, China.
China Pharmaceutical University · CNWuxi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is a common and serious mental disorder. Data on its pathogenesis remain unclear and the options of drug treatments are limited. Here, we explored the role of pyroptosis, a novel pro-inflammatory programmed cell death process, in depression as well as the anti-depression effects and mechanisms of salidroside (Sal), a bioactive extract from

Indexed as

depressionNLRP3P2X7pyroptosissalidroside

Identifiers

PMID35496273
PMCPMC9039222
OpenAlexW4223549863

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.